Benzinga's Top Upgrades

Analysts at JMP Securities upgraded Edwards Lifesciences EW from “market perform” to “outperform.” The target price for Edwards Lifesciences is set to $97. Edwards Lifesciences' shares closed at $80.71 yesterday. Nomura upgraded Marvell Technology Group MRVL from “neutral” to “buy.” The target price for Marvell Technology has been raised from $15 to $19. Marvell Technology's shares closed at $14.83 yesterday. Analysts at Baird upgraded Achillion Pharmaceuticals ACHN from “neutral” to “outperform.” The target price for Achillion Pharmaceuticals has been raised from $4 to $12. Achillion's shares closed at $7.79 yesterday. Analysts at Bank of America upgraded SanDisk SNDK from “underperform” to “buy.” SanDisk's shares closed at $97.14 yesterday.